Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already declare readOnly, idempotent, and non-destructive behavior. The description adds meaningful behavioral context beyond those flags: it lists exactly what data is returned, notes the cap of 'up to 10 study locations,' and identifies the underlying ClinicalTrials.gov v2 API source.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.